PLUS 2016 stakeholder consensus meeting held in Estoril
The PLUS 2016 stakeholder consensus meeting was held on 14-15 January in Estoril, Portugal. The event was attended by numerous patient organisations including IPOPI, EHC, WFH, HAEI, Alpha-1 Global, A-PLUS, and stakeholder organisations including EBA, IFBDO, IBTS, IPFA, PPTA and EPCC. The meeting was chaired by William Murphy with the support of Brian O’Mahony and Johan Prévot.
The introduction session featured an informative presentation by IPOPI’s Medical Advisory Panel member Prof Martin Van Hagen on “the importance of optimized access to Plasma Derived Medicinal Products (PDMPs): the example of IG therapies” as well as presentations by Sebastian Rohde on the “EU Blood Directive Background & considerations” and by Prof Albert Farrugia on “ongoing developments on donor selection from MSM”. The meeting was then structured into two sessions focusing on:
- Session 1: Blood and Plasma Regulations – Towards a revision of the EU Blood Directive: What is needed in a new Directive / Should Plasma be included in the Blood directive ?
- Session 2: MSM and Blood Donations